Gilead posts solid Q1 2026 growth & raises full-year outlook on HIV momentum

Brinton Pharma appoints Sathya Narayanan as CEO – India Cluster & JPAC

Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets

Symeres appoints Henning Steinhagen as CEO to drive next phase of global growth

Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector

FUJIFILM Biosciences & NextCell launch platform to standardize regenerative medicine development

The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows

Moderna’s mRNA flu vaccine outperforms standard shot in Phase 3 trial

NEJM study shows strong protection across strains

Dabur profit jumps 16% as FMCG growth gains pace

Hair care & quick commerce shine

Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO

The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform

ADMA Biologics wins FDA nod to expand ASCENIV use in young children

GRIN Therapeutics launches Phase 3 beeline study in Europe for radiprodil in GRIN-NDD

This is an exciting and meaningful milestone for GRIN Therapeutics

Merck completes $5.8 billion acquisition of Terns Pharma

At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia